Pain Management: Most Read Stories From 2024
Drug Topics
DECEMBER 27, 2024
Check out this list of our top 5 most read pain management stories from the year 2024.
Trending Articles
185 
Opinion: The DEA’s 2025 quotas for opioids will leave seriously ill patients in pain
STAT
DECEMBER 27, 2024
A woman sat in our emergency department in agonizing pain, feeling shaky, nauseous, and weak — drug withdrawal was setting in. But she wasn’t a “junkie” or even a recreational drug user. She was in her mid-60s with advanced cancer in her ovaries that had spread to her abdomen, causing unbearable pain. She was my patient — let’s call her Teresa.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Low Reimbursement, Coverage Restrictions Hinder Access to Vaccines
Drug Topics
DECEMBER 23, 2024
Researchers reviewed Medicaid policies to understand vaccine coverage and reimbursement rates among physicians and pharmacists.
Dupilumab Lowers Incidence of Psychiatric and Sleep Disorders in Patients With Atopic Dermatitis
Pharmacy Times
DECEMBER 24, 2024
The monoclonal antibody demonstrates the ability to reduce the incidence and improve symptoms related to sleep disorders and psychiatric disorders such as anxiety.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Could Ozempic prevent heart attack and stroke?
The Checkup by Singlecare
DECEMBER 23, 2024
In a world where the battle against obesity and diabetes is more pressing than ever, a groundbreaking medication is making waves for its dual capabilities. Ozempic (active ingredient semaglutide), a prescription medication manufactured by Novo Nordisk, is approved by the U.S. Food and Drug Administration (FDA) to help control blood sugar in patients with Type 2 diabetes.
Novo gets the green light for once-daily haemophilia drug following setbacks
Pharmaceutical Technology
DECEMBER 24, 2024
The FDA initially rejected the marketing application for Alhemo in 2022, asking for additional data on dosing and monitoring.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Sanofi takes SK Bio-partnered pneumococcal shot into phase 3
pharmaphorum
DECEMBER 24, 2024
Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines.
ASHP Midyear: Pharmacists Play Key Role in Comprehensive COPD Management, Emphasizing Cost Considerations
Pharmacy Times
DECEMBER 24, 2024
Pharmacists can significantly improve chronic obstructive pulmonary disease (COPD) management by promoting non-pharmacological interventions.
Are Compounding Pharmacies Safe? Everything You Need to Know
Compounding Pharmacy of America
DECEMBER 23, 2024
Learn how compounding pharmacies ensure safety and reliability through rigorous standards, sterile preparations, and personalized solutions for unique healthcare needs. The post Are Compounding Pharmacies Safe? Everything You Need to Know appeared first on Compounding Pharmacy of America.
FDA approves Lilly’s obesity med Zepbound to treat obstructive sleep apnoea
Pharmaceutical Technology
DECEMBER 23, 2024
Lillys Zepbound has become the first prescription medicine approved to treat adults with moderate to severe obstructive sleep apnoea (OSA) and obesity.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Amid BIOSECURE Act speculation, WuXi AppTec sells unit
pharmaphorum
DECEMBER 27, 2024
WuXi AppTec has agreed to sell a business unit serving the cell and gene therapy (CGT) sector to private equity firm Altaris for an undisclosed sum
RECAP: 2024 Updates in the GLP-1 Space
Pharmacy Times
DECEMBER 24, 2024
Despite the explosion of public interest in these drugs, ongoing shortages and debates over compounding made access difficult.
‘Wild west’: experts concerned by illegal promotion of weight-loss jabs in UK
The Guardian - Pharmaceutical Industry
DECEMBER 25, 2024
Guardian review finds many online pharmacies flouting strict advertising rules that govern prescription-only drugs Weight-loss injections are being aggressively marketed to British consumers through often illegal promotions, in a practice experts have described as a wild west industry of drug selling. The booming market for jabs such as Wegovy and Mounjaro has triggered a price battle among online pharmacies, with even high-street chains cashing in on the soaring demand.
Fierce Healthcare - Untitled Article
Fierce Healthcare
DECEMBER 23, 2024
Despite significant headwinds coming to bear over the past several years, healthcare executives are expecting a favorable 2025, according to a new survey from Deloitte.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
COVID-19: Most Read Stories From 2024
Drug Topics
DECEMBER 24, 2024
Check out this list of our top 5 most read COVID-19 stories from the year 2024.
FDA approves flurry of drugs ahead of holiday season
pharmaphorum
DECEMBER 24, 2024
The FDA has wrapped up a series of new approvals as 2024 draws to a close, with Novo Nordisk, Pfizer, Vertex, and Hikma among the beneficiaries.
Mild IVIG-Related Adverse Events Are Frequent in Children, With Serious Reactions Possible
Pharmacy Times
DECEMBER 24, 2024
Factors associated with intravenous immunoglobulin (IVIG)-related adverse events include older age, dehydration, and administration of multiple IVIG infusions.
Gender-affirming surgery disappeared from the U.S. for decades. Now the field is fighting to keep its gains
STAT
DECEMBER 23, 2024
For patients who receive gender-affirming surgery, the experience can feel like a rebirth. “I decided that the old me would die on the table and then the new me would come up from it,” said Wendy Grogan, 48, a trans woman who recently pursued vocal and facial procedures, top surgery, and a vaginoplasty — the creation of a vagina from a penis, scrotum, and other tissue.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
What pharmacists should know about the new drugs approved in 2024
The Checkup by Singlecare
DECEMBER 26, 2024
2024 has been a busy year for new drugs. Over 40 new medications have been approved by the FDA, giving patients more options for treating various health problems. These new drugs cover a wide range of conditions, from urinary tract infections to rare genetic disorders. Notable new drugs approved in 2024 By staying up-to-date on the latest drug approvals, pharmacists can give new advice when working with patients and other healthcare providers.
Infectious Disease: Most Read Stories From 2024
Drug Topics
DECEMBER 28, 2024
Check out this list of our top 5 most read infectious disease stories from the year 2024.
AZ gets EU okay for Tagrisso in early-stage lung cancer
pharmaphorum
DECEMBER 24, 2024
AstraZeneca's EGFR inhibitor Tagrisso has become the first drug in the class to be approved in the EU for a form of early-stage lung cancer.
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
Pharmacy Times
DECEMBER 24, 2024
In this episode of Public Health Matters, Christina Madison discusses the concept of reproductive justice and ensuring Black maternal health efforts are not left behind with Regina Davis Moss of In Our Own Voice.
Merry Christmas!
OctariusRx
DECEMBER 24, 2024
Merry Christmas! Thank you to our clients, family, and friends for all your support this year. Our entire team is grateful for our blessings and the wonderful people we work with. Whether you joined us this December, or have been with us for many years, thank you for allowing us to take care of you. We appreciate your trust and support. A successful year would be impossible without our hardworking team.
‘It’s absolutely open to abuse’: web awash with weight-loss drug offers
The Guardian - Pharmaceutical Industry
DECEMBER 25, 2024
Readers describe aggressive online promotions, Black Friday deals and special offers for prescription-only drugs After Andy King was told he was not eligible to receive weight-loss jabs on the NHS, he turned to the internet to order them privately. But before long, he was inundated with promotions. Every other advert on my social media feed is an offer to have a Black Friday deal on the drugs, he said.
Women’s Health: Most Read Stories From 2024
Drug Topics
DECEMBER 29, 2024
Check out this list of our top 5 most read womens health stories from the year 2024.
Daiichi and AZ pull Dato-DXd filing in Europe too
pharmaphorum
DECEMBER 24, 2024
AstraZeneca and Daiichi Sankyo have decided to voluntarily withdraw their EU marketing application for Dato-DXd in lung cancer.
Collective Responsibility, Confidence in Immunizations Indicate Potential of Vaccine Refusal
Pharmacy Times
DECEMBER 27, 2024
Individuals who refused a pneumococcal vaccine were associated with low collective responsibility and confidence in vaccine efficacy and safety.
Opinion: Extending Medicare coverage to obesity medications is imperative
STAT
DECEMBER 30, 2024
Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than a decade, the Congressional Budget Office (CBO) ventured to estimate the budgetary effects of such a policy for older Americans starting in 2026 for the very first time in a report published in October. The CBO should be commended for conducting this comprehensive analysis.
Shrinking waistlines and growing profits: the weight-loss drug boom
The Guardian - Pharmaceutical Industry
DECEMBER 25, 2024
Drugs such as Wegovy amd Mounjaro are an attractive prospect for online businesses and traditional pharmacies as well as the firms that make them It is a trend rooted in profit-making. Adverts featuring prescription-only weight-loss medications are splashed across the internet and it is causing concern among experts. But the question remains: who is driving the boom?
Cardiology: Most Read Stories From 2024
Drug Topics
DECEMBER 26, 2024
Check out this list of our top 5 most read cardiology stories from the year 2024.
Generative AI in pharma: Moving beyond hype and into widespread adoption
pharmaphorum
DECEMBER 27, 2024
Discover how Generative AI is revolutionising the pharmaceutical industry and moving beyond hype towards widespread adoption in drug discovery and development. Learn more about the impact of GenAI.
FDA Approves First Generic of Liraglutide Injection to Lower Blood Sugar in Patients With Type 2 Diabetes
Pharmacy Times
DECEMBER 23, 2024
The approval of the generic to liraglutide injection, currently in shortage, could help increase patient access to the type 2 diabetes treatment.
XBiotech halts all rheumatology research after missing Phase II endpoints
Pharmaceutical Technology
DECEMBER 24, 2024
XBiotech has said it will investigate the results of its rheumatoid arthritis trial after finding irregularities in its Phase II trial.
Let's personalize your content